Nachrichten zur Veru Inc. Aktie

XFRA : FMW: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

Strength Seen in Veru Inc. (VERU): Can Its 39.5% Jump Turn into More Strength?

Veru Inc. (VERU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…

Veru Shares Up 36% After FDA Panel Document Cites Clinical Benefit of Covid-19 Drug

Veru Shares Up 36% After FDA Panel Document Cites Clinical Benefit of Covid-19 Drug...…

Veru Shares Jump Over 40% Despite FDA Staff Raises Uncertainties Over Its COVID-19 Therapy

Veru Inc (NASDAQ: VERU) is set to face an FDA Advisory Committee meeting on Wednesday regarding its emergency use authorization (EUA)…

Why Veru Stock Is Skyrocketing Today

Investors are reacting positively to an FDA briefing document....…

Thinking about buying stock in Nio, Xpeng, Veru, Carvana, or Alibaba?

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, XPEV, VERU, CVNA, and BABA. To…

Veru jumps 19% ahead of FDA AdCom meeting on COVID-19 therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biotech-Industrie: Deutsche Biotech-Firma will bessere Therapien für schwerstkranke Covid-Patienten auf den Weg bringen

Mit neuartigen Entzündungshemmern treten die Unternehmen Inflarx und Veru bei der US-Arzneimittelbehörde an. Sie wollen die Überlebenschancen bei schweren Covidfällen…

Veru to Present Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week 2022

MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel…

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MIAMI, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel…

dpa-AFX ProFeed